ABG
NERV icon

Ally Bridge Group’s Minerva Neurosciences NERV Stock Holding History

Ally Bridge Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
2,175,802
+520,302
+31% +$2.82M 10.68% 3
2026
Q1 		$9.97M Hold
1,655,500
– – 8.06% 2
2025
Q4 		$6.66M Buy
+1,655,500
New +$6.15M 6.93% 7

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM

Ally Bridge Group's NERV Position: Q2 2026 in Review

Ally Bridge Group increased its Minerva Neurosciences (NERV) stake by 31% in Q2 2026, buying an estimated $2.82M and bringing the position to 2,175,802 shares worth $12.1M. The position accounts for 10.68% of the portfolio, ranked #3.

Ally Bridge Group first reported a position in NERV in Q4 2025 and has held it in 3 quarters since. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Ally Bridge Group held 2,175,802 shares of Minerva Neurosciences worth $12.1M as of Q2 2026.
  • Ally Bridge Group bought 520,302 Minerva Neurosciences shares in Q2 2026, an estimated $2.82M.
  • Minerva Neurosciences made up 10.68% of Ally Bridge Group's portfolio in Q2 2026, its #3 holding.
  • Ally Bridge Group first reported a position in Minerva Neurosciences in Q4 2025 and has held it in 3 quarters since.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Ally Bridge Group's 13F filing for Q2 2026, filed 14 Aug 2026.